AU775885B2 - Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder - Google Patents

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder Download PDF

Info

Publication number
AU775885B2
AU775885B2 AU14402/01A AU1440201A AU775885B2 AU 775885 B2 AU775885 B2 AU 775885B2 AU 14402/01 A AU14402/01 A AU 14402/01A AU 1440201 A AU1440201 A AU 1440201A AU 775885 B2 AU775885 B2 AU 775885B2
Authority
AU
Australia
Prior art keywords
salt
aminoindan
alkyl
hydrogen
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU14402/01A
Other languages
English (en)
Other versions
AU1440201A (en
Inventor
Gabriela Barak
Ruth Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU1440201A publication Critical patent/AU1440201A/en
Application granted granted Critical
Publication of AU775885B2 publication Critical patent/AU775885B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU14402/01A 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder Ceased AU775885B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16181799P 1999-10-27 1999-10-27
US60/161817 1999-10-27
PCT/US2000/029618 WO2001030339A1 (en) 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

Publications (2)

Publication Number Publication Date
AU1440201A AU1440201A (en) 2001-05-08
AU775885B2 true AU775885B2 (en) 2004-08-19

Family

ID=22582876

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14402/01A Ceased AU775885B2 (en) 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

Country Status (9)

Country Link
US (1) US6492426B1 (enExample)
EP (1) EP1242066B1 (enExample)
JP (1) JP2003512426A (enExample)
AT (1) ATE331508T1 (enExample)
AU (1) AU775885B2 (enExample)
CA (1) CA2387394C (enExample)
DE (1) DE60029131T2 (enExample)
IL (2) IL149308A0 (enExample)
WO (1) WO2001030339A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140090996A (ko) * 2011-10-10 2014-07-18 테바 파마슈티컬 인더스트리즈 리미티드 R(+)-n-폼일-프로파길-아미노인단
US9181026B2 (en) 2013-10-03 2015-11-10 Custom Chemical Solutions, LLC Containment berm with internal “L” braces
WO2024196698A2 (en) * 2023-03-17 2024-09-26 Curadh Mtr Compounds and constructs useful for targeting fibroblast activation protein

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
US3886168A (en) * 1971-07-26 1975-05-27 Basf Ag N-substituted 1-aminomethylindanes
US4096173A (en) * 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852735A (en) 1956-04-13 1960-11-02 Schering Ag Manufacture of 1-aminoindanes
JPS5824433A (ja) * 1981-08-06 1983-02-14 Takehiro Mokuzai Kogyo Kk 繊維材成型品の表面化粧方法
SE464194B (sv) 1983-03-04 1991-03-18 Otsuka Pharma Co Ltd Indanderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner
EP0173331B1 (en) 1984-08-31 1991-08-14 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1h-indene derivatives, a process for preparing them and pharmaceutical compositions containing same
US5242919A (en) 1984-08-31 1993-09-07 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1H-indene derivatives
JPS6169747A (ja) 1984-08-31 1986-04-10 Otsuka Pharmaceut Co Ltd ２，３―ジヒドロ―１ｈ―インデン誘導体及びその製造法
US4882339A (en) 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL92952A (en) 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
IL99759A (en) 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
US5344836A (en) 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
CH683996A5 (fr) 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
KR100238346B1 (ko) 1993-04-07 2000-03-02 오쓰까 아끼히꼬 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제
IL111240A (en) 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
AU1867095A (en) 1994-01-10 1995-08-01 Technion Research & Development Foundation Ltd. 1-aminoindan derivatives and compositions thereof
US5877218A (en) 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
CH690264A5 (fr) 1995-06-30 2000-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
US5646188A (en) 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5887218A (en) 1996-06-10 1999-03-23 Ricoh Co., Ltd. Color image forming apparatus having toner and transfer sheet bearing members and image forming method thereof
DE69732984T2 (de) 1996-12-18 2006-02-16 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
WO1998055447A1 (en) 1997-06-05 1998-12-10 Venantius Limited 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
US5887221A (en) 1997-10-20 1999-03-23 Xerox Corporation Signature sensing for optimum toner control with donor roll
US6227886B1 (en) 1999-04-16 2001-05-08 Avaya Technology Corp. Snag-resistant patchcord plug latch and cover

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
US3886168A (en) * 1971-07-26 1975-05-27 Basf Ag N-substituted 1-aminomethylindanes
US4096173A (en) * 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors

Also Published As

Publication number Publication date
JP2003512426A (ja) 2003-04-02
EP1242066A4 (en) 2004-09-01
CA2387394A1 (en) 2001-05-03
AU1440201A (en) 2001-05-08
IL149308A0 (en) 2002-11-10
EP1242066B1 (en) 2006-06-28
WO2001030339A1 (en) 2001-05-03
CA2387394C (en) 2009-08-18
IL149308A (en) 2007-07-24
DE60029131D1 (de) 2006-08-10
US6492426B1 (en) 2002-12-10
ATE331508T1 (de) 2006-07-15
EP1242066A1 (en) 2002-09-25
DE60029131T2 (de) 2007-01-18

Similar Documents

Publication Publication Date Title
US20100256145A1 (en) Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
CA2180841C (en) 1-aminoindan derivatives and compositions thereof
KR20060135781A (ko) 질병의 치료를 위한 아민 및 아미드
CN109627186B (zh) 氨基羰基氨基甲酸酯化合物
KR101500962B1 (ko) 정신 장애의 치료에 유용한 알파­아미노아미드 유도체
AU775885B2 (en) Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
CN109824637A (zh) 一种茚酮查尔酮氨基甲酸酯类化合物及其制备方法和用途
US20050119285A1 (en) Treatment of neurological disorders related to rapid eye movement (REM) sleep disturbances with NPY Y5 receptor antagonists
WO2010126527A1 (en) Methods of treating cns disorders
AU2006231117A1 (en) Therapeutic use of nefopam and analogues thereof
Mahaney et al. Structure− Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors
PT1745786E (pt) Compostos neuroprotetores e composições farmacêuticas que os compreendem
Batista et al. The phthalimide analogues N-3-hydroxypropylphthalimide and N-carboxymethyl-3-nitrophthalimide exhibit activity in experimental models of inflammatory and neuropathic pain
Pugsley et al. Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities
JP2011088919A (ja) アゴメラチンとノルアドレナリン再取り込み阻害剤との新たな組み合わせ、及びそれを含有している医薬組成物
US20040254173A1 (en) Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines
JP2006316056A (ja) 双極性障害を処置するための医薬を得るためのアゴメラチンの使用
MX2008015434A (es) Combinanciones de inhibidores de recaptacion de monoamina y activadores de canales de potasio.
TW201811761A (zh) 用於治療用途之化合物
RS4604A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola u vezi sa klasterskim i migrenskim glavoboljama
JP2025539118A (ja) シグマ－１受容体及び可溶性エポキシドヒドロラーゼの二重阻害剤、並びに疼痛の治療におけるその使用
RS4504A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola u vezi sa klasterskim i migrenskim glavoboljama
JP2022510362A (ja) Ｒ－２－（置換スルホニル）－ヘキサヒドロ－ピロロ［１，２－ａ］ピラジン－６（２Ｈ）－オンとＳ－２－（置換スルホニル）－ヘキサヒドロ－ピロロ［１，２－ａ］ピラジン－６（２Ｈ）－オンを非ラセミ比で含む相乗的組成物
HK40058361B (zh) (2，5-二氧代吡咯烷-1-基)(苯基)-乙酰胺衍生物及其在治疗神经系统疾病中的用途
US20080033045A1 (en) Treatment of psychiatric disorders